A high level of SerpinE1 has been revealed to be associated with a poor prognosis of breast cancer [41] where it was significantly associated with metastasis and invasion; consequently, it has been validated clinically in breast cancer as a biomarker [42]. Here, SERPINE1 is linked to breast carcinoma.